Published in Prog Neuropsychopharmacol Biol Psychiatry on September 11, 2007
Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression. Brain Behav Immun (2013) 0.98
Mechanisms of antidepressant resistance. Front Pharmacol (2013) 0.92
Clinical and molecular genetics of psychotic depression. Schizophr Bull (2013) 0.76
Mindfulness based cognitive therapy for psychiatric disorders: a systematic review and meta-analysis. Psychiatry Res (2010) 3.46
Mindfulness-based stress reduction for stress management in healthy people: a review and meta-analysis. J Altern Complement Med (2009) 2.89
The genetic determinants of smoking. Chest (2003) 2.88
Does mindfulness training improve cognitive abilities? A systematic review of neuropsychological findings. Clin Psychol Rev (2010) 2.17
Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry (2010) 2.17
Non-prescribed use of pain relievers among adolescents in the United States. Drug Alcohol Depend (2007) 2.11
The epidemiology of the dementias: an update. Curr Opin Psychiatry (2007) 2.05
Prevalence of pathological internet use among adolescents in Europe: demographic and social factors. Addiction (2012) 2.01
Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.98
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2012) 1.70
Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project. J Am Geriatr Soc (2007) 1.65
Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depress Anxiety (2005) 1.64
Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates? Eur J Pediatr (2007) 1.62
Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry (2007) 1.60
Morbidity and related factors among elderly people in South Korea: results from the Ansan Geriatric (AGE) cohort study. BMC Public Health (2007) 1.59
A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression. J Clin Psychopharmacol (2006) 1.57
Mindfulness-based interventions for chronic pain: a systematic review of the evidence. J Altern Complement Med (2011) 1.54
Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity. J Biol Chem (2004) 1.53
Bioactive triterpenoids from Callistemon lanceolatus. Arch Pharm Res (2009) 1.51
Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet B Neuropsychiatr Genet (2003) 1.50
The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder. Eur Arch Psychiatry Clin Neurosci (2012) 1.49
Antidepressant effects of light therapy combined with sleep deprivation are influenced by a functional polymorphism within the promoter of the serotonin transporter gene. Biol Psychiatry (2003) 1.48
Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda. Clin Gastroenterol Hepatol (2012) 1.47
Buprenorphine treatment: factors and first-hand experiences for providers to consider. J Addict Dis (2007) 1.46
A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it. J Clin Psychiatry (2011) 1.45
Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia. Int J Neuropsychopharmacol (2004) 1.43
HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia. J Clin Psychopharmacol (2015) 1.42
Phototargeting oral black-pigmented bacteria. Antimicrob Agents Chemother (2005) 1.42
Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial. J Clin Psychopharmacol (2005) 1.41
Validation of the Patient Health Questionnaire-9 Korean version in the elderly population: the Ansan Geriatric study. Compr Psychiatry (2007) 1.41
Prescription pain reliever abuse and dependence among adolescents: a nationally representative study. J Am Acad Child Adolesc Psychiatry (2008) 1.40
Genetic dissection of psychopathological symptoms: insomnia in mood disorders and CLOCK gene polymorphism. Am J Med Genet B Neuropsychiatr Genet (2003) 1.39
Seasonal variations of lithium plasma levels. Psychiatry Res (2002) 1.38
Are mindfulness-based interventions effective for substance use disorders? A systematic review of the evidence. Subst Use Misuse (2013) 1.37
Decreased plasma antioxidants in patients with Alzheimer's disease. Int J Geriatr Psychiatry (2006) 1.37
Telephone enhancement of long-term engagement (TELE) in continuing care for substance abuse treatment: a NIDA clinical trials network (CTN) study. Am J Addict (2007) 1.37
Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression. Am J Med Genet B Neuropsychiatr Genet (2007) 1.35
Usefulness of Beck Depression Inventory (BDI) in the Korean elderly population. Int J Geriatr Psychiatry (2007) 1.34
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy. Eur Neuropsychopharmacol (2011) 1.33
Serotonin transporter gene variants and behavior: a comprehensive review. Curr Drug Targets (2006) 1.29
Pharmacogenetics of antidepressant response. J Psychiatry Neurosci (2011) 1.28
An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study. J Stud Alcohol Drugs (2009) 1.27
Personality and attempted suicide. Analysis of anger, aggression and impulsivity. J Psychiatr Res (2009) 1.26
A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet (2003) 1.25
A Glu487Lys polymorphism in the gene for mitochondrial aldehyde dehydrogenase 2 is associated with myocardial infarction in elderly Korean men. Clin Chim Acta (2007) 1.24
New antipsychotics and schizophrenia: a review on efficacy and side effects. Curr Med Chem (2004) 1.22
Relationship between Psychological Factors and Quality of Life in Subtypes of Gastroesophageal Reflux Disease. Gut Liver (2009) 1.21
Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. J Clin Psychiatry (2002) 1.14
Mindfulness: top-down or bottom-up emotion regulation strategy? Clin Psychol Rev (2012) 1.14
The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. Contemp Clin Trials (2008) 1.14
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.14
The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study. Drug Alcohol Depend (2009) 1.13
The cutoff values of visceral fat area and waist circumference for identifying subjects at risk for metabolic syndrome in elderly Korean: Ansan Geriatric (AGE) cohort study. BMC Public Health (2009) 1.12
HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Curr Med Chem (2007) 1.11
A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett (2004) 1.11
Interaction between serotonin transporter gene, catechol-O-methyltransferase gene and stressful life events in mood disorders. Int J Neuropsychopharmacol (2006) 1.10
Psychometric properties of the Patient Health Questionnaire-15 (PHQ-15) for measuring the somatic symptoms of psychiatric outpatients. Psychosomatics (2009) 1.10
No difference in stroke knowledge between Korean adherents to traditional and western medicine - the AGE study: an epidemiological study. BMC Public Health (2006) 1.10
Assessment of the type D personality construct in the Korean population: a validation study of the Korean DS14. J Korean Med Sci (2010) 1.09
Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. Am J Med Genet B Neuropsychiatr Genet (2005) 1.09
Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett (2008) 1.09
Comment and reply on: antidepressant for depressed patients with pain. Expert Opin Investig Drugs (2012) 1.08
Altered cerebellar-cerebral functional connectivity in geriatric depression. PLoS One (2011) 1.08
Gene environment interaction studies in depression and suicidal behavior: An update. Neurosci Biobehav Rev (2013) 1.07
Possible association between -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population. Psychiatr Genet (2003) 1.07
Increased recognition of depression in primary care. Comparison between primary-care physician and ICD-10 diagnosis of depression. Psychother Psychosom (2005) 1.07
Pet therapy in elderly patients with mental illness. Psychogeriatrics (2010) 1.05
Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study. Psychopharmacology (Berl) (2009) 1.05
Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data. CNS Drugs (2011) 1.05
The 5-HTTLPR polymorphism and eating disorders: a meta-analysis. Int J Eat Disord (2011) 1.05
Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP. Neurosci Lett (2004) 1.04
Mental health of healthcare workers who experience needlestick and sharps injuries. J Occup Health (2006) 1.04
Pharmacogenetics in major depression: a comprehensive meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry (2013) 1.03
Heterogeneity of stimulant dependence: a national drug abuse treatment clinical trials network study. Am J Addict (2009) 1.03
Depressive symptomatology is influenced by chronotypes. J Affect Disord (2009) 1.02
Mirtazapine for patients with alcohol dependence and comorbid depressive disorders: a multicentre, open label study. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.02
Paroxetine mesylate: comparable to paroxetine hydrochloride? Expert Opin Pharmacother (2010) 1.02
A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neurosci Lett (2004) 1.02
Serotonergic genes and suicide: a systematic review. Eur Neuropsychopharmacol (2013) 1.01
Depression is associated with sarcopenia, not central obesity, in elderly korean men. J Am Geriatr Soc (2011) 1.00
Focus on HTR2C: A possible suggestion for genetic studies of complex disorders. Am J Med Genet B Neuropsychiatr Genet (2009) 0.99
Cognitive status, depressive symptoms, and health status as predictors of functional disability among elderly persons with low-to-moderate education: The Faenza Community Aging Study. Am J Geriatr Psychiatry (2005) 0.99